Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer

References

• American Cancer Society. (2016). Cancer facts & figures 2016. Atlanta: American Cancer Society.
   Google Scholar
• Clark PE, Agarwal N, Biagioli MC, et al. (2013). Bladder cancer. Bladder Cancer 11:446–75.
   Google Scholar
• Sylvester RJ, Van Der Meijden APM, Oosterlinck W, et al. (2006). Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466–75.
   PubMed Web of Science ®Google Scholar
• Wientjes MG, Dalton JT, Badalament RA, et al. (1991). Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res 51:4347–54.
   PubMed Web of Science ®Google Scholar
• Wientjes MG, Badalament RA, Wang RC, et al. (1993). Penetration of mitomycin C in human bladder. Cancer Res 53:3314–20.
   PubMed Web of Science ®Google Scholar
• Wientjes MG, Badalament RA, Au JL. (1996). Penetration of intravesical doxorubicin in human bladders. Cancer Chemother Pharmacol Pharm 37:539–46.
   PubMed Web of Science ®Google Scholar
• Knemeyer I, Wientjes MG, Au JL-S. (1999). Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment. Cancer Chemoth Pharm 44:241–8.
   PubMed Web of Science ®Google Scholar
• Au JL-S, Badalament RA, Wientjes MG, et al. (2001). Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst 93:597–604.
   PubMed Web of Science ®Google Scholar
• Gan Y, Wientjes MG, Badalament RA. (1996). Pharmacodynamics of doxorubicin in human bladder tumors. Clin Cancer Res 2:1275–83.
   PubMed Web of Science ®Google Scholar
• Dalton JT, Wientjes MG, Badalament RA, et al. (1991). Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Res 51:5144–52.
   PubMed Web of Science ®Google Scholar
• Hu L, Wientjes MG, Li J, Au JL-S. (2010). Bladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogs. AAPS J 12:586–91.
   PubMed Web of Science ®Google Scholar
• Tammela T, Wein AJ, Monson FC, Levin RM. (1993). Urothelial permeability of the isolated whole bladder. Neurourol Urodyn 12:39–47.
   PubMed Web of Science ®Google Scholar
• Van Der Heijden AG, Verhaegh G, Jansen CFJ, et al. (2005). Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. J Urol 173:1375–80.
   PubMed Web of Science ®Google Scholar
• Urano M, Kuroda M, Nishimura Y. (1999). For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperther 15:79–107.
   PubMed Web of Science ®Google Scholar
• Owusu RA, Abern MR, Inman BA. (2013). Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer. Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer. Biomed Res Int 2013:262313.
   PubMed Web of Science ®Google Scholar
• Paroni R, Salonia A, Lev A, et al. (2001). Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Brit J Clin Pharmacol 52:273–8.
   PubMed Web of Science ®Google Scholar
• Milla P, Fiorito C, Soria F, et al. (2014). Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients. Cancer Chemoth Pharm 73:503–9.
   PubMed Web of Science ®Google Scholar
• Lammers RJM, Witjes JA, Inman BA, et al. (2011). The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol 60:81–93.
   PubMed Web of Science ®Google Scholar
• Arends TJH, Nativ O, Maffezzini M, et al. (2016). Results of a randomised controlled trial comparing intravesical chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol 69:1046–52.
   PubMed Web of Science ®Google Scholar
• Ranjan A, Jacobs GC, Woods DL, et al. (2012). Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release 158:487–94.
   PubMed Web of Science ®Google Scholar
• Celsion. (2016). Study of ThermoDox with standardized radiofrequency ablation (RFA) for treatment of hepatocellular carcinoma (HCC) (OPTIMA): NLM identifier NCT02112656; [Dec 2016]. Available from: https://clinicaltrials.gov/ct2/show/NCT02112656.
   Google Scholar
• Gasselhuber A, Dreher MR, Negussie A, et al. (2010). Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperther 26:499–513.
   PubMed Web of Science ®Google Scholar
• Gasselhuber A, Dreher MR, Partanen A, et al. (2012). Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivo validation. Int J Hyperther 28:337–48.
   PubMed Web of Science ®Google Scholar
• Prozorowska E, Jackowiak H. (2014). The vascular corrosion casting (VCC) and scanning electron microscopy study on changes of vascular networks arrangement in the organs undergoing cyclic volume changes. In: Méndez-Vilas A, ed. Microscopy: advances in scientific research education. 6th ed. Badajoz, Spain: Formatex Research Center, 112–18.
   Google Scholar
• Nielsen KK. (1995). Blood flow rate and total blood flow related to length density and total length of blood vessels in mini-pig urinary bladder after chronic outflow obstruction and after recovery from obstruction. Neurourol Urodyn 14:177–86.
   PubMed Web of Science ®Google Scholar
• Qin H-y, Sun H, Wang X, et al. (2013). Correlation between CT perfusion parameters and microvessel density and vascular endothelial growth factor in adrenal tumors. PLoS One 8:e79911.
   PubMed Web of Science ®Google Scholar
• Incropera FP, DeWitt DP. (2006). Introduction to convection. Fundamentals of heat and mass transfer. 6th ed. New York: John Wiley & Sons, 347–400.
   Google Scholar
• Mcintosh RL, Anderson V. (2010). A comprehensive tissue properties database provided for the thermal assessment of a human at rest. Biophys Rev Lett 5:129–51.
   Google Scholar
• Duck FA. (1990). Thermal properties of tissue. Physical properties of tissue: a comprehensive reference book. London: Academic Press, 167–223.
   Google Scholar
• Nielsen KK, Nielsen SL, Nordling J, Kromann-Andersen B. (1991). Rate of urinary bladder blood flow evaluated by 133Xe washout and radioactive microspheres in pigs. Urol Res 19:387–91.
   PubMedGoogle Scholar
• Gasselhuber A, Dreher MR, Rattay F, et al. (2012). Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model. PLoS One 7:e47453.
   PubMed Web of Science ®Google Scholar
• Manzoor A, Lindner LH, Landon CD, et al. (2012). Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res 72:5566–75.
   PubMed Web of Science ®Google Scholar
• Wientjes MG, Dalton JT, Badalament RA, et al. (1991). A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall. Pharm Res 8:168–73.
   PubMed Web of Science ®Google Scholar
• Al-Abd AM, Kim NH, Song SC, et al. (2009). A simple HPLC method for doxorubicin in plasma and tissues of nude mice. Arch Pharm Res 32:605–11.
   PubMed Web of Science ®Google Scholar
• Stauffer PR, van Rhoon GC. (2016). Overview of bladder heating technology: matching capabilities with clinical requirements. Int J Hyperther 32:407–16.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cheng KS, Craciunescu OI, et al. (2012). Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys 39:1170–81.
   PubMed Web of Science ®Google Scholar
• Schooneveldt G, Bakker A, Balidemaj E, et al. (2016). Thermal dosimetry for bladder hyperthermia treatment. An overview. Int J Hyperther 32:417–33.
   PubMed Web of Science ®Google Scholar
• Needham D, Dewhirst MW. (2001). The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 53:285–305.
   PubMed Web of Science ®Google Scholar
• Colombo R, Da Pozzo LF, Lev A, et al. (1996). Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol 155:1227–32.
   PubMed Web of Science ®Google Scholar
• Colombo R, Da Pozzo LF, Lev A, et al. (1998). Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 159:783–7.
   PubMed Web of Science ®Google Scholar
• Wood BJ, Poon RT-P, Locklin JK, et al. (2012). Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol 23:248–55.
   PubMed Web of Science ®Google Scholar
• Swenson CE, Haemmerich D, Maul DH, et al. (2015). Increased duration of heating boosts local drug deposition during radiofrequency ablation in combination with thermally sensitive liposomes (ThermoDox) in a porcine model. PLoS One 10:e0139752.
   PubMed Web of Science ®Google Scholar
• Sercombe L, Veerati T, Moheimani F, et al. (2015). Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Bedocs P, Csukas D, et al. (2012). A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines. Adv Drug Deliv Rev 64:1706–16.
   PubMed Web of Science ®Google Scholar
• Hakenberg OW, Linne C, Manseck A, Wirth MP. (2000). Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement. Neurourol Urodynam 19:585–93.
   PubMed Web of Science ®Google Scholar
• Manieri C, Carter SS, Romano G, et al. (1998). The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol 159:761–5.
   PubMed Web of Science ®Google Scholar
• Miodonski AJ, Litwin JA. (1999). Microvascular architecture of the human urinary bladder wall: a corrosion casting study. Anat Rec 254:375–81.
   PubMedGoogle Scholar